UPDATE: The Trump administration has decided Medicare will NOT pay for the popular GLP-1 drugs just for weight loss. It would have cost the government nearly $40 Billion over 10 years.
Perhaps the hottest, most divisive topic in health care is obesity. Which in the US appears to have stabilized in 2024 at about 40% of adults. Is obesity a disease or a lifestyle result? How does it affect overall health and what diseases can it cause? Who should take the expensive new GLP-1 weight loss drugs like Wegovy? And perhaps the most divisive issue - who should pay for those drugs – and how. Get ready for a great conversation with tons of useful information from my guest Dr. Naser Gharaibeh, MD, CPE, DABOM, NCMP – who heads the Valley Health System Center for Weight and Wellness in New Jersey. Dr. Gharaibeh is board certified in obesity medicine as well as endocrinology, diabetes, metabolism and internal medicine.
Note: all episodes are also available in video form on YouTube
Popular Podcasts
24/7 News: The Latest
The latest news in 4 minutes updated every hour, every day.
Therapy Gecko
An unlicensed lizard psychologist travels the universe talking to strangers about absolutely nothing. TO CALL THE GECKO: follow me on https://www.twitch.tv/lyleforever to get a notification for when I am taking calls. I am usually live Mondays, Wednesdays, and Fridays but lately a lot of other times too. I am a gecko.
The Joe Rogan Experience
The official podcast of comedian Joe Rogan.